This Is MS Multiple Sclerosis Community: Knowledge & Support

https://www.youtube.com/watch?v=7o2c2gkjV4c

Has anyone seen the Brave Dreams results? I can't see how he would have got them to use the video-clip method, so maybe it's irrelevant. Because the MS population has been divided and conquered, I don't see anyone demanding answers anymore. Are we losing? The other side has the advantage: we all die young. The only answer is to outlive them. And to teach the next generation not to accept any more bullshit. If ...

http://www.ajnr.org/content/22/6/1186.short

The Petrosquamosal Sinus: CT and MR Findings of a Rare Emissary Vein
K. Marsot-Dupucha, M. Gayet-Delacroixa, M. Elmaleh-Bergèsa, F. Bonnevillea and P. Lasjaunias a
+ Author Affiliations

aFrom Service de NeuroRadiologie (K.M-D., F.B., P.I.), Hôpital Bicêtre, Le Kremlin-Bicêtre, Service de Radiologie (M.G-D.), Hôtel Dieu, Nantes, and Service de Radiologie (M.E-B.), Hôpital Robert Debré, Paris, France.
Abstract

BACKGROUND AND PURPOSE: Morphologic changes in the dural sinuses and emissary veins ...

http://m.ebm.sagepub.com/content/early/ ... 6.abstract

This is an article about ligation of external and internal jugular veins in mice in order to create a mouse model of CCSVI in a recent 2016 study, but as far as I know, it doesn't address the concern that cerebrospinal drainage in mice is not primarily through the jugular veins. I had to look up the name of the vein in mice, it's in this ...

http://multiplesclerosisnewstoday.com/2 ... cognition/

It would be more useful if they also gathered information on slowed blood flow out of the brain, aka blocked jugulars, to tie in to the data they're collecting on blood flow within the brain and oxygen use within the brain and neuropsychological testing. Still I'm interested in what they find out with this study.

http://www.yourhoustonnews.com/memorial ... 1a460.html

McGuckin, James Frederick, Jr., M.D., Lic. No. N1760, Philadelphia, PA

On June 10, 2016, the Board and James Frederick McGuckin, Jr., M.D., entered into an Agreed Order requiring Dr. McGuckin to comply with all terms as required by the Agreed Order issued by the Washington Medical Quality Assurance Commission. Dr. McGuckin shall not perform angioplasty and stenting procedures of the venous system for chronic cerebrospinal venous ...

The FDA has recently approved a bioresorbable stent. Could these one day be used for CCSVI?

http://www.peoplespharmacy.com/2016/07/ ... ike-magic/

First Stent That the Body Can Resorb:

Now, the FDA has approved the first stent made of a polymer that gradually dissolves in the body. The bioresorbable vascular scaffold system disintegrates in about three years, leaving no trace. It appears to be roughly as effective as standard stents in preventing ...

http://gofundme.com/2bhxt6rg is the url for my project.

This month was published that a mutation in gene NR1H3 was heavily related to familial PPMS. The big news for CCSVI is that this gene is involved in the production of the protein LXRA, and if we look in wikipedia:

https://en.wikipedia.org/wiki/Liver_X_receptor_alpha

we find that it interacts with EDF1, other protein involved in the endothelium.

https://en.wikipedia.org/wiki/EDF1

Besides, LXRA is also related to the metabolism ...

According to this article, an advanced CCSVI diagnostic center will be opened in a few months in Ferrara:

http://www.osservatoriomalattierare.it/attualita/10599-ccsvi-nascera-a-ferrara-centro-pubblico-di-diagnosi-avanzata

This is translated from an original article in Italian, and I think that a little may be lost in the translation. I found the article on the internet:

CCSVI, will be born in Ferrara center of advanced diagnostic audience

Author: Drafting, May 20, 2016

An advanced CCSVI diagnostic center will be opened in a few months ...

The Central Vein Sign on SWI at 3T MRI Differentiates Multiple Sclerosis from Neuromyelitis Optica

http://www.neurology.org/content/86/16_ ... .147.short


Abstract

OBJECTIVE: To assess the discriminatory value of the central vein sign (CVS) on susceptibility-weighted imaging (SWI) acquired on a clinical scanner (3T) between neuromyelitis optica spectrum disorders (NMOSD) and multiple sclerosis (MS).

BACKGROUND: It would be useful to identify brain magnetic resonance imaging (MRI) features that help to differentiate between ...